ClinVar Miner

Submissions for variant NM_000390.4(CHM):c.877C>T (p.Arg293Ter)

dbSNP: rs132630266
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000078687 SCV000110547 pathogenic not provided 2013-10-29 criteria provided, single submitter clinical testing
GeneDx RCV000078687 SCV000680505 pathogenic not provided 2017-12-12 criteria provided, single submitter clinical testing The R293X variant in the CHM gene has been reported previously (also as R294X due to alternate nomenclature) in multiple unrelated patients with choroideremia (van Bokhoven et al., 1994; Jolly et al., 2015; McLaren et al., 2015; Sanchez-Alcudia et al., 2016). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R293X variant is not observed in large population cohorts (Lek et al., 2016). We interpret R293X as a pathogenic variant.
CeGaT Center for Human Genetics Tuebingen RCV000078687 SCV001248391 pathogenic not provided 2017-08-01 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000078687 SCV001377144 pathogenic not provided 2024-11-05 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg293*) in the CHM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHM are known to be pathogenic (PMID: 9067750, 23811034). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with choroidemia (PMID: 26133251, 28559085). ClinVar contains an entry for this variant (Variation ID: 11154). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Ophthalmic Genetics Group, Institute of Molecular and Clinical Ophthalmology Basel RCV000011904 SCV004030378 pathogenic Choroideremia 2023-07-24 criteria provided, single submitter research Clinical significance based on ACMG v2.0
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg RCV004814884 SCV005068433 pathogenic Retinal dystrophy 2023-01-01 criteria provided, single submitter clinical testing
OMIM RCV000011904 SCV000032137 pathogenic Choroideremia 1994-07-01 no assertion criteria provided literature only
Sharon lab, Hadassah-Hebrew University Medical Center RCV000011904 SCV001160981 pathogenic Choroideremia 2019-06-23 no assertion criteria provided research
GeneReviews RCV000011904 SCV002012455 not provided Choroideremia no assertion provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.